The pharmaceutical warehousing market is driven by a kaleidoscope of influencers who shape the overall market structure and its growth pattern through various mechanisms. Intensifying international requirements for pharmaceutical products is another major market variable. As the world population and ageing population keep on increasing, the demand too for healthcare and medications is consequently on the increase. Such increase in demand for medicine sends the rift in the pharmaceutical warehousing and facilitates the demand for effective storage, handling and distribution of drugs.
In addition, stringent regulatory conditions are shaping the pharmaceutical storage market in accordance with the market. The pharmaceutical industry is governed under strict regulatory frameworks to guarantee the safety and efficacy of all drugs. Storage facilities are bound to apply the Good Distribution Practice (GDP) norms and even other regulatory standards to ensure the intactness of pharmaceuticals until the arrival ends. While fulfilling the legal requirements alone without producing trust among stakeholders and consumers may not only be legal but also very risky.
The size of the market of pharmaceutical warehousing was the sum of 48.57 billion in 2022. It is expected that the pharmaceutical and medical warehouse market will be USD 51.62 billion in 2023 and USD 89.31 billion in 2032, at an average annual growth rate (AAGR) of 6.28 %.
One of the other fundamental factors of market that influences the pharmaceutical warehousing is an advancement of technology. The way that automation, robotics, and digital systems had been utilized made storage operations more advanced. Automated storage and retrieval systems, sensors for temperature control and real-time tracking systems have somewhat increased the productiveness, accuracy and safety of drug storages. With the help of IT the current processes in operations are improved and the costs are reduced whereas overall management of the supply chain is facilitated.
The spread of globalization and the development of pharmaceutical companies into the new markets are the multi-faceted factors of the pharmaceutical warehousing business. The more companies expand onto the global platform, the more diverse the regulatory fields, the different logistical difficulties, and distinct requirements of the market they get to face. This obliges the creation of well located depots and distribution centers to facilitate cheaper and immediate delivery of the pharmaceutical products.
Market competition, which pushes the strategies applied by pharmaceutical warehousing providers, is the main driving force of this issue. In this highly competitive scenario, companies hope to set themselves apart by offering extra services like temperature controlled storage, fast response to the market demand through the use of inventory management, and personalized packaging. Through the project, a competitive environment has been created that stimulates innovation in the warehousing area and motivates providers to follow up on the new developments and future technologies.
Report Attribute/Metric | Details |
---|---|
Growth Rate | 6.28% (2023-2032) |
Pharmaceutical Warehousing Market size was valued at USD 48.57 billion in 2022. The Pharmaceutical Warehousing Market industry is projected to grow from USD 51.62 billion in 2023 to USD 89.31 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.28% during the forecast period (2023 - 2032).
The macro factors that are positively contributing to the growth of pharmaceutical warehousing are the rapid growth of the pharmaceutical industry and the increasing demand for temperature-controlled storage.
FIGURE 1: PHARMACEUTICAL WAREHOUSING MARKET, 2019 to 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The growth of the pharmaceutical warehousing market has been driven by multiple factors such as increasing demand for pharmaceutical products, rising global health concerns, and increasing investments in research and development. According to the Congressional Budget Office (US), the total R&D investment in the pharmaceutical industries was USD 83,000 million in the US in the year 2019. Moreover, the factors influencing the R&D spending are increasing private spending on R&D through programs which increases the demand for drugs. Furthermore, as per the European Pfizer Policy, it has been estimated that the R&D investment in pharmaceutical industries was USD 37,800 million in Europe in 2019 and USD 39,000 million in 2020.
Additionally, the increasing demand for temperature-controlled storage is burgeoning the growth of the pharmaceutical warehousing market. This is due to the biological nature of pharmaceutical products, complex molecules & biologics, and rising demand for vaccines in both developed and developing regions. According to the United Nations International Children's Emergency Fund, the East Asia-Pacific region exhibited significant recovery in vaccination and immunization up to 7% from 82% in 2021 to 89% in 2022 due to increasing coverage. This positive trend has been seen in Indonesia, the Philippines, Vietnam, and Myanmar.
Therefore, increasing demand of pharmaceutical products and rising need of vaccination and immunization is burgeoning the growth of Pharmaceutical Warehousing Market.
A brand-new, cutting-edge temperature-controlled warehousing system from Catalent was introduced in 2023 specifically for the storage of medications that are sensitive to temperature. This facility has computerized inventory management and cutting-edge monitoring technologies.
A brand-new AI-driven warehouse management system (WMS) designed specifically for pharmaceutical storage was unveiled by Warehousing1 in 2023. Artificial intelligence is used by this system to maximize order fulfillment, inventory control, and regulatory compliance.
The Pharmaceutical Warehousing Market is segmented, based on service type, into storage, distribution, inventory management, packaging, and others. The storage segment held the majority share of the market, with a market share in 2022 and is the fastest-growing segment during the forecast year. The demand for storage services is increasing owing to rising demand for pharmaceuticals and the need for temperature-controlled storage. There are major players such as Thermo Fisher Scientific, Inc. (US), UPS (US), and SGS S.A. (Switzerland), which provide cost-effectiveness, efficiency, security, and improved product stability services in pharma warehouses.
The Pharmaceutical Warehousing Market segmentation, based on mode, includes cold chain warehouses and non-cold chain warehouses. The non-cold chain warehouses segment dominated the market in the base year, i.e., 2022, and cold chain warehouses segment is the fastest-growing segment during the forecast period, 2023–2032. This is due to the wide range of advantages offered by cold chain warehouses, such as maintaining the integrity of pharmaceutical products, preventing product recalls, ensuring compliance with regulations, and improving efficiency.
Therefore, the broad range of advantages of cold chain warehouses for pharmaceutical products and the fact that, as the demand for pharmaceutical products continues to grow, the use of cold chain warehouses is likely to increase are propelling the cold chain warehouse segment's growth.
FIGURE 2: PHARMACEUTICAL WAREHOUSING MARKET, BY MODE, 2022 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Based on end user, the Pharmaceutical Warehousing Market has been segmented into pharmaceutical companies, hospitals & clinics, research institutes & government agencies, and others. The pharmaceutical companies segment dominated the market in the base year, i.e., 2022, and is the fastest-growing segment during the forecast period. Furthermore, the factors influencing the growth of the pharmaceutical companies’ segment are increasing demand for pharmaceutical products, rising approval of new drugs, and increasing incidences of chronic diseases. The US Food and Drug Administration has reported that the Center for Drug Evaluation and Research (CDER) has approved 37 novel drugs.
Hence, high demand for innovative drugs to treat illnesses requires a customized environment for storage, fostering the pharmaceutical company segment's growth.
By region, the study segments the market into North America, Europe, Asia-Pacific, and the rest of the world. In North America, the pharmaceutical warehousing market held the largest market share in 2022 due to the increasing need for pharmaceutical products. As per the IQVIA (US) 2022 report, new pharmaceutical medicine sales were up 67.7% in the US during the 2016–2021 period. In addition, the rising incidences of chronic diseases, including cancer, obesity, diabetes, and cardiac diseases, are raising the demand for pharmaceutical products in hospitals & clinics. According to the American Heart Association, cardiovascular diseases (CVD) are the leading cause of death among the US population and accounted for 928,741 deaths in 2020.
Hence, the rising demand for pharmaceutical products and increasing incidences of chronic diseases are fueling segment growth in the North American pharmaceutical warehousing market.
Further, the major countries studied are: The US, Canada, France, Germany, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
FIGURE 3: PHARMACEUTICAL WAREHOUSING MARKET, BY REGION, 2022 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The European pharmaceutical warehousing market accounted for the second-largest market share due to increasing launch of pharma warehouses. For instance, in September 2020, Maersk Line (Denmark) launched pharmaceutical warehouse in Poland which is fully compliant with European Good Distribution Practice and has carbon neutral facility to meet increased customer needs. Moreover, the European Commission 2020 report on Pharmaceutical Strategy for Europe revealed that expenditure on medicines in hospital settings accounted for 20% to 30% of hospital expenditure and is growing rapidly. Furthermore, the France pharmaceutical warehousing market held the largest market in 2022, and the UK pharmaceutical warehousing market is projected to be the fastest-growing market in the Europe region.
The Asia-Pacific pharmaceutical warehousing market is the fastest-growing region from 2023 to 2032, owing to the launch of pharmaceutical warehouse services and the rising geriatric population in the region. For instance, in March 2023, Cargo-partner (Austria) launched the Pharma Competence Center in Shanghai, China, to meet the demand of customers in the increasingly important consumer market in China for pharmaceuticals and healthcare products. Furthermore, as per the Asia-Pacific Report on Population Ageing 2022, there were approximately 672 million people aged 60 or older in Asia-Pacific in 2022; further 886 million and 1,340 million will be in 2030 and 2050, respectively. The growing geriatric population is increasing the demand of pharmaceutical products in hospitals & clinics. Moreover, the China pharmaceutical warehousing market accounted for the largest market share in 2022, and the India pharmaceutical warehousing market is projected to be the fastest-growing market in the Asia-Pacific region.
The pharmaceutical warehousing market is highly competitive due to factors such as increasing demand of pharmaceutical products from hospitals & clinics and government agencies. Moreover, global logistics companies such as UPS (US), SGS S.A. (Switzerland), and DB Schenker (Germany) offer pharmaceutical warehousing services as part of their comprehensive supply chain solutions. They leverage their extensive networks, technology infrastructure, and international reach to provide end-to-end pharmaceutical logistics. These companies excel in offering scale, reliability, and integrated solutions for pharmaceutical companies with extensive global operations.
DB Schenker (Germany) is the world's leading logistics provider. It offers warehousing services in more than 100 countries, which include both contract and value-added services. It has a presence in all regions, namely the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Furthermore, in September 2020, the company launched its largest warehousing facility in Gurugram, India, in order to strengthen its footprint in India. This warehouse provides pharmaceutical services to meet the demands of customers.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)